Skip to main
  1. Stocks
  2. Oscar Health
  3. Forecast
OSCR

Oscar Health (OSCR) Stock Forecast & Price Target

Oscar Health (OSCR) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 0%
Buy 33%
Hold 56%
Sell 11%
Strong Sell 0%

Bulls say

Oscar Health is well positioned by its improving underwriting profile, with 3Q26 risk adjustment payable guidance revised to (17.5%) from (20.0%) at the midpoint and MLR improved to 81.0%, signaling better-than-expected claims dynamics and a path toward roughly 80% MLR over time. Management also raised 2026 expectations for Earnings from Operations to $600 million to $800 million while keeping revenue at $18.7 billion to $19.0 billion and SG&A at 15.6% to 16.1%, showing operating leverage even amid ACA volatility. Longer term, the thesis is supported by projected ACA individual market growth to ~23 million lives by 2029, over 20% revenue CAGR from 2026-2029, and $4.0B-$4.5B of targeted cumulative internal capital generation.

Bears say

Oscar Health is priced for a 14.0% weighted average rate increase in CY27, but that pricing appears to assume a flat Individual ACA market at 17.0M only briefly before normal contraction to 13.9M-15.4M by Dec-27, pressuring the company to gain share merely to keep membership flat. The firm may benefit from competitor exits and its tech-forward managed care platform, yet the analyst remains cautious because the ACA risk pool could worsen as program integrity controls, metal-tier mix shifts, and post-subsidy behavior complicate the true level of sustainable enrollment. With expected CY26 membership of 2.5M and an implied need to reach 17.3% market share to offset a smaller market, the outlook remains negative on uncertainty around morbidity and medical loss ratio adequacy.

Oscar Health (OSCR) has been analyzed by 9 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 33% recommend Buy, 56% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.

Oscar Health (OSCR) Analyst Forecast & Price Prediction

Get the latest Oscar Health (OSCR) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Oscar Health (OSCR)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Oscar Health (OSCR) Forecast

Analysts have given Oscar Health (OSCR) a Hold based on their latest research and market trends.

According to 9 analysts, Oscar Health (OSCR) has a Hold consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $34.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $34.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Oscar Health (OSCR)


Oscar Health (OSCR) Analyst Forecast & Price Prediction

Get the latest Oscar Health (OSCR) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Oscar Health (OSCR)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover OSCR stock data and trends